Avalo Therapeutics, Inc.AVTXNASDAQ
Loading
Book Value/Share Growth Under PressureDecelerating
Percentile Rank23
Studio
Year-over-Year Change

Year-over-year book value per share growth

Percentile
P23
Within normal range
vs 2Y Ago
-0.6x
Contraction
Streak
2 yr
Consecutive declineDecelerating
PeriodValue
2025-62.14%
2024-37.77%
2023109.45%
2022-143.66%
2021-33.76%
2020-8.98%
2019-38.92%
2018-60.27%
20176355.52%
2016-99.60%